SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-289713
Filing Date
2018-10-01
Accepted
2018-10-01 17:11:36
Documents
8
Period of Report
2018-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d612604d8k.htm 8-K 23855
2 EX-1.1 d612604dex11.htm EX-1.1 70889
3 EX-4.1 d612604dex41.htm EX-4.1 98118
4 EX-5.1 d612604dex51.htm EX-5.1 10090
5 EX-10.1 d612604dex101.htm EX-10.1 183993
6 EX-99.1 d612604dex991.htm EX-99.1 9645
7 GRAPHIC g612604001.jpg GRAPHIC 25192
8 GRAPHIC g612604g1001205625840.jpg GRAPHIC 3915
  Complete submission text file 0001193125-18-289713.txt   438416
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 181098380
SIC: 2835 In Vitro & In Vivo Diagnostic Substances